The presence of an HLA-identical sibling donor has no impact on outcome of patients with high-risk MDS or secondary AML (sAML) treated with intensive chemotherapy followed by transplantation: results of a prospective study of the EORTC, EBMT, SAKK and GIMEMA Leukemia Groups (EORTC study 06921)

✍ Scribed by Oosterveld, M; Suciu, S; Verhoef, G; Labar, B; Belhabri, A; Aul, C; Selleslag, D; Ferrant, A; Wijermans, P; Mandelli, F

• Book ID: 110055443
• Publisher: Nature Publishing Group
• Year: 2003
• Tongue: English
• Weight: 170 KB
• Volume: 17
• Category: Article
• ISSN: 0887-6924
• DOI: 10.1038/sj.leu.2402897